0001140361-24-017909.txt : 20240404 0001140361-24-017909.hdr.sgml : 20240404 20240404151419 ACCESSION NUMBER: 0001140361-24-017909 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20240404 DATE AS OF CHANGE: 20240404 EFFECTIVENESS DATE: 20240404 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Pacylex Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001866841 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-509694 FILM NUMBER: 24822895 BUSINESS ADDRESS: STREET 1: 400 3RD AVENUE SW, SUITE 3700 CITY: CALGARY STATE: A0 ZIP: T2P 4H2 BUSINESS PHONE: 780-264-4295 MAIL ADDRESS: STREET 1: 400 3RD AVENUE SW, SUITE 3700 CITY: CALGARY STATE: A0 ZIP: T2P 4H2 D 1 primary_doc.xml X0708 D LIVE 0001866841 Pacylex Pharmaceuticals Inc. 400 3rd Avenue SW Suite 3700 Calgary A0 ALBERTA, CANADA T2P 4H2 780-264-4295 CANADA (FEDERAL LEVEL) None None Corporation true Cindy Jacobs c/o Pacylex Pharmaceuticals Inc. 400 3rd Avenue SW, Suite 3700 Calgary A0 ALBERTA, CANADA T2P 4H2 Director Mark Huson c/o Pacylex Pharmaceuticals Inc. 400 3rd Avenue SW, Suite 3700 Calgary A0 ALBERTA, CANADA T2P 4H2 Director Michael Weickert c/o Pacylex Pharmaceuticals Inc. 400 3rd Avenue SW, Suite 3700 Calgary A0 ALBERTA, CANADA T2P 4H2 Director Executive Officer Luc G. Berthiaume c/o Pacylex Pharmaceuticals Inc. 400 3rd Avenue SW, Suite 3700 Calgary A1 BRITISH COLUMBIA, CANADA T2P 4H2 Director John Mackey c/o Pacylex Pharmaceuticals Inc. 400 3rd Avenue SW, Suite 3700 Calgary A0 ALBERTA, CANADA T2P 4H2 Director Ryan Heit c/o Pacylex Pharmaceuticals Inc. 400 3rd Avenue SW, Suite 3700 Calgary A0 ALBERTA, CANADA T2P 4H2 Executive Officer Ajit Gill c/o Pacylex Pharmaceuticals Inc. 400 3rd Avenue SW, Suite 3700 Calgary A0 ALBERTA, CANADA T2P 4H2 Director Nola Masterson c/o Pacylex Pharmaceuticals Inc. 400 3rd Avenue SW, Suite 3700 Calgary A0 ALBERTA, CANADA T2P 4H2 Director Pharmaceuticals Decline to Disclose 06c false 2024-03-21 false true true false 0 75000 75000 0 This filing covers, in part, the sale of common shares issued as a result of the conversion of convertible notes. false 3 0 0 0 Pacylex Pharmaceuticals Inc. /s/ Ryan Heit Ryan Heit Chief Operating Officer 2024-04-04